News
![engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering](https://pharmaphorum.com/wp-content/uploads/2018/12/wednesday-image.jpg)
Cash round sets up trial of InteRNA’s microRNA for cancer
Dutch biotech InteRNA Technologies has raised €18.5 million ($22 million) in second-round financing as it prepares to start clinical trials of its lead drug candidate INT-1B3 for solid tumo